Human liver quality is a dominant factor in the outcome of in vitro studies

[1]  J. Tredger,et al.  Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. , 1999, Mutation research.

[2]  J. Silva,et al.  Cryopreservation of rat and human liver slices by rapid freezing. , 1999, Cryobiology.

[3]  A. Li,et al.  Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: Evaluation of model drugs terfenadine and rifampin , 1997, Cell Biology and Toxicology.

[4]  R. Ulrich,et al.  Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development. , 1995, Toxicology letters.

[5]  G. Groothuis,et al.  Comparison of human hepatocytes isolated from livers accepted or discarded for orthotopic transplantation. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  M. Wang,et al.  Effective cryopreservation and long-term storage of primary human hepatocytes with recovery of viability, differentiation, and replicative potential. , 1995, Cell transplantation.

[7]  A. Vickers.  Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals , 1994, Cell Biology and Toxicology.

[8]  A. J. Gandolfi,et al.  Comparative toxicity of valproic acid and its metabolites in liver slices from adult rats, weanling rats and humans. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  O. Boillot,et al.  Early graft function in liver transplantation: comparison of two techniques of graft procurement. , 1993, Transplantation proceedings.

[10]  A. J. Gandolfi,et al.  Cold- and cryopreservation of dog liver and kidney slices. , 1993, Cryobiology.

[11]  S. Knechtle,et al.  Update on preservation of liver grafts. , 1993, Transplantation proceedings.

[12]  G. Gores,et al.  Carolina rinse solution decreases liver injury during clinical liver transplantation. , 1993, Transplantation proceedings.

[13]  D. Alexander,et al.  U.S. system for organ procurement and transplantation. , 1992, American journal of hospital pharmacy.

[14]  A. J. Gandolfi,et al.  In- Vitro Hepatotoxicity of Three Dichlorobenzene Isomers in Human Liver Slices , 1991, Human & experimental toxicology.

[15]  J. Wolf.  The role of the United Network for Organ Sharing and designated organ procurement organizations in organ retrieval for transplantation. , 1991, Archives of pathology & laboratory medicine.

[16]  T. Starzl,et al.  Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury , 1990, Hepatology.

[17]  J B Houston,et al.  In vitro human tissue models in risk assessment: report of a consensus-building workshop. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  A. Vickers,et al.  Changes in human liver and kidney slice function related to potential side-effects in the presence of biotransformation of four cyclosporin derivatives : CSA, IMM, OG, and PSC , 1998 .

[19]  J. Tredger,et al.  3,3'-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  J B Houston,et al.  Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. , 1997, Drug metabolism reviews.

[21]  A. J. Gandolfi,et al.  Dynamic Organ Culture is Superior to Multiwell Plate Culture for Maintaining Precision-Cut Tissue Slices: Optimization of Tissue Slice Culture, Part 1 , 1995 .

[22]  I. Sipes,et al.  Metabolism of dichlorobenzenes in organ cultured liver slices. , 1991, Advances in experimental medicine and biology.

[23]  A. J. Gandolfi,et al.  Valproic acid hepatotoxicity in human liver slices. , 1991, Drug and chemical toxicology.